These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30731397)

  • 1. Structure-based drug design, synthesis, In vitro, and In vivo biological evaluation of indole-based biomimetic analogs targeting estrogen receptor-α inhibition.
    Hendy MS; Ali AA; Ahmed L; Hossam R; Mostafa A; Elmazar MM; Naguib BH; Attia YM; Ahmed MS
    Eur J Med Chem; 2019 Mar; 166():281-290. PubMed ID: 30731397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, in silico and biological evaluation of new indole based oxadiazole derivatives targeting estrogen receptor alpha.
    Kaur K; Verma H; Gangwar P; Jangid K; Dhiman M; Kumar V; Jaitak V
    Bioorg Chem; 2024 Jun; 147():107341. PubMed ID: 38593531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of novel indole-xanthendione hybrids as selective estrogen receptor modulators.
    Singla R; Gupta KB; Upadhyay S; Dhiman M; Jaitak V
    Bioorg Med Chem; 2018 Jan; 26(1):266-277. PubMed ID: 29198894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of novel indole-benzimidazole hybrids targeting estrogen receptor alpha (ER-α).
    Singla R; Gupta KB; Upadhyay S; Dhiman M; Jaitak V
    Eur J Med Chem; 2018 Feb; 146():206-219. PubMed ID: 29407951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, and
    Choudhari RC; Kaur K; Das A; Jaitak V
    Curr Comput Aided Drug Des; 2024; 20(5):640-652. PubMed ID: 37888813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and anticancer/antiestrogenic activities of novel indole-benzimidazoles.
    Karadayi FZ; Yaman M; Kisla MM; Keskus AG; Konu O; Ates-Alagoz Z
    Bioorg Chem; 2020 Jul; 100():103929. PubMed ID: 32464404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural product-inspired rational design, synthesis and biological evaluation of 2,3-dihydropyrano[2,3-f]chromen-4(8H)-one based hybrids as potential mitochondrial apoptosis inducers.
    Sakthivel P; Ilangovan A; Kaushik MP
    Eur J Med Chem; 2016 Oct; 122():302-318. PubMed ID: 27376493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2H-chromen-2-one derivatives targeting ERα as anti-breast cancer agents.
    Luo G; Chen M; Lyu W; Zhao R; Xu Q; You Q; Xiang H
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2668-2673. PubMed ID: 28460819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of leads targeting ER-α in breast cancer: An in silico exploration from natural domain.
    Ashtekar SS; Bhatia NM; Bhatia MS
    Steroids; 2018 Mar; 131():14-22. PubMed ID: 29307843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of novel dual-acting modulators targeting both estrogen receptor α (ERα) and lysine-specific demethylase 1 (LSD1) for treatment of breast cancer.
    He M; Ning W; Hu Z; Huang J; Dong C; Zhou HB
    Eur J Med Chem; 2020 Jun; 195():112281. PubMed ID: 32283297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of targeted dibenzo[b,f]thiepines and dibenzo[b,f]oxepines as potential lead molecules with promising anti-breast cancer activity.
    Ansari MI; Hussain MK; Arun A; Chakravarti B; Konwar R; Hajela K
    Eur J Med Chem; 2015 Jun; 99():113-24. PubMed ID: 26067208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, antiproliferative activity and estrogen receptor α affinity of novel estradiol-linked platinum(II) complex analogs to carboplatin and oxaliplatin. Potential vector complexes to target estrogen-dependent tissues.
    Saha P; Descôteaux C; Brasseur K; Fortin S; Leblanc V; Parent S; Asselin E; Bérubé G
    Eur J Med Chem; 2012 Feb; 48():385-90. PubMed ID: 22209414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, pharmacological evaluation and docking studies of progesterone and testosterone derivatives as anticancer agents.
    Jabeen M; Choudhry MI; Miana GA; Rahman KM; Rashid U; Khan HU; Arshia ; Sadiq A
    Steroids; 2018 Aug; 136():22-31. PubMed ID: 29772243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and evaluation of 6-aryl-indenoisoquinolone derivatives dual targeting ERα and VEGFR-2 as anti-breast cancer agents.
    Tang Z; Wu C; Wang T; Lao K; Wang Y; Liu L; Muyaba M; Xu P; He C; Luo G; Qian Z; Niu S; Wang L; Wang Y; Xiao H; You Q; Xiang H
    Eur J Med Chem; 2016 Aug; 118():328-39. PubMed ID: 27176944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico discovery and validation of potent small-molecule inhibitors targeting the activation function 2 site of human oestrogen receptor α.
    Singh K; Munuganti RS; Leblanc E; Lin YL; Leung E; Lallous N; Butler M; Cherkasov A; Rennie PS
    Breast Cancer Res; 2015 Feb; 17(1):27. PubMed ID: 25848700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: Synthesis, biological activities in vitro and docking study.
    Lamie PF; Ali WAM; Bazgier V; Rárová L
    Eur J Med Chem; 2016 Nov; 123():803-813. PubMed ID: 27541263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and anti-proliferative activity of 1-(4-methoxyphenyl)-12-hydroxymethyl-p-carborane derivatives.
    Kaise A; Ohta K; Endo Y
    Eur J Med Chem; 2016 Oct; 122():257-263. PubMed ID: 27371927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SAR study of tyrosine-chlorambucil hybrid regioisomers; synthesis and biological evaluation against breast cancer cell lines.
    Descôteaux C; Brasseur K; Leblanc V; Parent S; Asselin E; Bérubé G
    Amino Acids; 2012 Aug; 43(2):923-35. PubMed ID: 22102055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, cytocidal activity and estrogen receptor α affinity of doxorubicin conjugates at 16α-position of estrogen for site-specific treatment of estrogen receptor positive breast cancer.
    Saha P; Fortin S; Leblanc V; Parent S; Asselin É; Bérubé G
    Steroids; 2012 Sep; 77(11):1113-22. PubMed ID: 22801351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and antiproliferative activity of a novel class of indole-2-carboxylate derivatives.
    Ji XY; Xue ST; Zhan YC; Shen JJ; Wu LT; Jin J; Wang Z; Li ZR
    Eur J Med Chem; 2014 Aug; 83():409-18. PubMed ID: 24996136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.